Search - tctmd.com

Displaying 701 - 720 of 2031

Sort: Relevancy | Date

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

News Daily News

Complete Revascularization May Top Culprit-Only PCI Across ACS Types

July 08, 2020

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

News Daily News

Polymer-Free DES Hold No Long-term Advantage: ISAR-TEST-5

Michael O'Riordan

July 07, 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

News Conference News EuroPCR 2020

DynamX Bioadaptor Provides Promising Preliminary Results for De Novo Coronary Lesions

June 30, 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

News Conference News EuroPCR 2020

No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms

Michael O'Riordan

June 26, 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

News Conference News EuroPCR 2020

Age May Impact Outcomes After PCI Choices Guided by FFR but Not iFR

June 26, 2020

Sodium Fluoride PET Bests CT for Predicting MI in CAD Patients

News Daily News

Sodium Fluoride PET Bests CT for Predicting MI in CAD Patients

Yael L. Maxwell

June 15, 2020

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

News Daily News

PCI for Left Main CAD: Meta-analysis Finds No Increased Risk of Mortality

Michael O'Riordan

June 12, 2020

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

News Daily News

YOUNG-MI: Quick EF Recovery Key to Cutting Deaths in Those Under 50

June 04, 2020

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

News Daily News

Swedish Data ‘Corroborate’ FFR’s Survival Benefit Seen in RCTs

June 03, 2020

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

News Daily News

New EXCEL Analysis Reignites Debate Over PCI for Left Main CAD

Michael O'Riordan

June 01, 2020

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

News Daily News

Complete Revascularization in STEMI Seems to Cut CV Mortality: Meta-analysis

May 27, 2020

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

May 22, 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presentation SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

May 15, 2020

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

May 08, 2020

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

News Daily News

Multivessel PCI May Be Safe in Select Shock Patients With Impella Support

April 29, 2020

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

News Features

Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance

April 29, 2020

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

News Daily News

Functionally Significant Nonculprit Lesions Pose Risk in STEMI Patients

Michael O'Riordan

April 21, 2020

Aspirin Okay for Up to 30 Days

News Conference News ACC 2020

Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI: AUGUSTUS

April 03, 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

April 02, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.